Skip to main content
. 2021 Aug 30;77(3):554–560. doi: 10.1093/gerona/glab247

Table 2.

Comparison of Gait, Cognitive, and Neuroimaging Measures at Baseline (2011) and Follow-up (n = 217)

Gait and Cognitive Measures Baseline (2011) Follow-up (2015) p-value
TUG time, seconds (mean [SD]) 9.14 (1.60) 10.07 (1.76) <.001
TUG steps, n (mean [SD]) 12.42 (1.70) 13.66 (2.09) <.001
Gait impairment, n (%) 10 (4.6) 27 (12.4) <.001
Cognitive index (mean [SD]) 0.28 (0.65) 0.23 (0.68) .015
Executive function (mean [SD]) 0.24 (0.70) 0.22 (0.69) .445
Psychomotor speed (mean [SD]) 0.32 (0.74) 0.27 (0.76) .022
Neuroimaging measures
Global efficiency (mean [SD]) 10.68 (2.26) 10.60 (2.39) .166
WMH, mL (median [IQR]) 2.50 [1.14, 6.53] 3.85 [1.76, 9.20] <.001
Lacunes presence, n (%) 26 (12.0) 48 (22.1) <.001
Microbleeds presence, n (%) 38 (17.5) 48 (23.0) .067
TBV, mL (mean [SD]) 1 096.38 (123.09) 1 074.54 (125.78) <.001

Notes: Data represent number of participants (%), mean ± SD or median (IQR). TBV = total brain volume; WMH = white matter hyperintensity.